Eurofins completes acquisition of Ascend Clinical
'Ascend's core competencies and customer relationships complement Eurofins' extensive portfolio of pre- and post-transplant services, resulting in a better and broader service offering for customers', explains the French group.
Patti Hunsader, Ascend's current COO, will take over as President of Ascend Clinical, and the company's management team will remain in place, continuing to drive growth as part of Eurofins' US clinical diagnostics business line.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction